Clinical Trial Update: Evaluation of the Efficacy of Rasagiline in Apathy in Drug-naïve Patients With Parkinson's Disease by a Multi-center Study [Phase 4]

View source ↗

Summary

A multi-center Phase 4 trial is evaluating the efficacy of rasagiline for apathy in drug-naïve patients with Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Apathy
• Parkinson Disease

Drugs mentioned

• Azilect (rasagiline)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Drug-naïve Patients With Parkinson's Disease, Apathy | Phase 4 | Status: UNKNOWN